Business Information
The group's principal activities are to design, develop, manufacture and distribute proprietary workstation and consumable products for medical and clinical laboratory applications. The products include workstation-systems and consumable diagnostic products, reagents and test kits. The workstation-system increases the accuracy and reduces the cost to perform routine laboratory analysis of various body fluids. The consumable diagnostic products, reagents and test kits facilitate accurate diagnosis of certain medical conditions. The group has been granted 20 patents on its r/s, fe, parasep and uriprep technologies and trade name protection for "Diasys" under the following product names (both domestically and abroad): urizyme, diasys, uriprep, parasep, urisep. The group markets its products through distributors in North America, Europe, Middle East, Africa, China and pacific Asia.
|
|
Name |
Title
|
Email
|
| Fredric Neikrug | CEO, Pres. | N/A | | Sherman Lazrus | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 1,688 | (1,048) | | 2005 | 1,914 | (2,029) | | 2004 | 1,863 | (2,986)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
